ArticlePLOS global public health2025
Determinants of cholera fatalities in Malawi: A case-control study of patient-level and clinical management factors in the 2022-23 outbreak.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Real-world effectiveness of oral cholera vaccine amid fragility: A case-control study from Eastern Sudan, 2024.IJID regions · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malawi experienced its deadliest cholera outbreak in 2022, reporting over 50,000 cases and more than 1,700 deaths. This situation was further exacerbated by the Tropical Cyclone Freddy, which caused widespread damage to health infrastructure and strained Malawi's limited healthcare resources. Despite the scale of the outbreak, no evaluations were conducted to identify risk factors associated with cholera-related mortality among hospitalized individuals. This study filled that gap by characterizing the clinical and treatment-related factors contributing to cholera mortality in Malawi. A retrospective matched case-control study was conducted in August 2023 across four high-burden cholera districts: Blantyre, Mangochi, Lilongwe, and Nkhatabay. Medical records of 174 laboratory-confirmed cholera patients admitted between March 2022 and September 2023 were reviewed, including 87 matched pairs of deceased (cases) and surviving (controls) patients by age group and district. Data were extracted using a standardized mortality audit tool capturing socio-demographic characteristics, care-seeking behaviour, clinical status, and treatment received. Conditional logistic regression was used to identify factors associated with cholera mortality. Inadequate intravenous fluid management within the first 6 hours of admission was the strongest predictor of mortality (adjusted OR = 45.26, 95% CI: 9.09-225.30, p < 0.001). Other factors such as clinical status on admission showed a trend toward association but did not reach statistical significance. Timely and appropriate intravenous fluid administration within the first 6 hours of care is critical to reducing cholera mortality. We highlight an urgent need to strengthen the early response capacity in cholera treatment units, particularly during climate-related public health emergencies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.